Induce Biologics Inc.
Invest PDF Print E-mail

Investment Opportunities: Induce Biologics has raised $11.4 million to date for the proof-of-priniciple work, manufacturing process development, and initial preclinical development.  Induce is now entering a significant phase of product development and hence provides a timely investment opportunity. Induce is currently seeking to raise a minimum of CAN$3 million to complete the GLP biocompatibility and toxicity testing needed to advance URIST™ to its first-in-human clinical trial, which is projected to begin in 2016, followed by CAN$6 million to complete the clinical trial.


For more information, please contact:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it



Follow InduceBio on Twitter and get all the updates regarding our latest activities, products, and future plans.

Follow Us on Twitter